Skip to main content
Fig. 5 | Clinical Epigenetics

Fig. 5

From: The predictive value of BTG1 for the response of newly diagnosed acute myeloid leukemia to decitabine

Fig. 5

The association of BTG1 expression at diagnosis and efficacy of decitabine + IA regimen. A Comparison of BTG1 expression among healthy controls, untreated patients and treated patients. B Comparison of BTG1 in patients with CR and non-CR, and among patients with MRD negativity and MRD positivity. C ROC curve of BTG1 mRNA for predicting CR in training cohort. D ROC curve of BTG1 mRNA for predicting MRD negativity in training cohort. E ROC curve of BTG1 mRNA for predicting CR in variation cohort. F ROC curve of BTG1 mRNA for predicting MRD negativity in variation cohort. G Comparison of RFS in patients with high and low BTG1 expression. H Comparison of OS in patients with high and low BTG1 expression

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us